comparemela.com
  1. Home
  2. Live Updates
  3. Cerevel Therapeutics Holdings - Breaking News

Latest Breaking News On - Cerevel therapeutics holdings - Page 11 : comparemela.com

Cerevel Therapeutics Holdings Insiders Placed Bullish Bets Worth US$2 51m

Multiple insiders secured a larger position in Cerevel Therapeutics Holdings, Inc. ( NASDAQ:CERE ) shares over the last.

Cerevel therapeutics holdingsCerevel therapeutics holdings insider transactionsCerevel therapeutics holdings boast high insider ownershipTherapeutics holdingsCerevel therapeuticsInsider transactions

CERE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Cerevel Therapeutics Holdings, Inc Is Fair to Shareholders

CERE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Cerevel Therapeutics Holdings, Inc Is Fair to Shareholders
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Zachary halperHalper sadehSale of cerevel therapeutics holdings incCerevel therapeutics holdings incAbbvie incInvestigating whetherCerevel therapeutics holdingsDaniel sadeh

CERE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Cerevel Therapeutics Holdings, Inc Is Fair to Shareholders -January 08, 2024 at 12:37 pm EST

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Cerevel Therapeutics Holdings, Inc. to AbbVie Inc. for $45.00 per share in cash is fair to Cerevel.

Zachary halperHalper sadehAbbvie incCerevel therapeutics holdings incCerevel therapeutics holdingsDaniel sadeh

Pfizer shares downgraded as patent expirations loom

Pfizer Inc. shares were downgraded to market perform from outperform at TD Cowen on Thursday, as analysts see upcoming patent expirations and shaky.

Pfizer incRoivant sciences ltdCerevel therapeutics holdings incRoivant sciencesCerevel therapeutics holdingsArticle normalPfizer incRoivant sciences ltdCerevel therapeutics holdings incS amp ampp 500 index

Cerevel Therapeutics Holdings, Inc (NASDAQ:CERE) Receives $37 82 Average PT from Analysts

Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Free Report) have been given a consensus recommendation of “Hold” by the eleven research firms that are currently covering the firm, Marketbeat Ratings reports. Nine investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The […]

United statesDsusan altschullerPiper sandlerJefferies financial groupAmeritas investment partners incCantor fitzgeraldCerevel therapeutics holdings incRoyal bankCentaurus financial incTower research capitalBain capital investors llcMorgan stanleySecurities exchange commissionCerevel therapeutics holdingsGet free reportMarketbeat ratings

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.